Article
Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency.
The Journal of biological chemistry - 6 Aug 2010
Drury Jason E, Mindnich Rebekka, Penning Trevor M
Abstract excerpt
Bile acid deficiency is a serious syndrome in newborns that can result in death if untreated. 5beta-Reductase deficiency is one form of bile acid deficiency and is characterized by dramatically decreased levels of physiologically active 5beta-reduced bile acids. AKR1D1 (aldo-keto reductase 1D1) is the only known human enzyme that stereo-specifically reduces the Delta(4) double bond in 3-keto steroids and sterols...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
